Compare GSAT & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GSAT | DVA |
|---|---|---|
| Founded | 2003 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Misc Health and Biotechnology Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 10.1B |
| IPO Year | 2006 | 2002 |
| Metric | GSAT | DVA |
|---|---|---|
| Price | $58.55 | $149.13 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 4 |
| Target Price | $70.50 | ★ $156.75 |
| AVG Volume (30 Days) | 497.8K | ★ 750.4K |
| Earning Date | 05-07-2026 | 02-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.58 | N/A |
| EPS | N/A | ★ 9.84 |
| Revenue | $112,660,000.00 | ★ $13,643,069,000.00 |
| Revenue This Year | $11.67 | $3.80 |
| Revenue Next Year | $14.74 | $3.04 |
| P/E Ratio | ★ N/A | $15.16 |
| Revenue Growth | N/A | ★ 6.46 |
| 52 Week Low | $17.24 | $101.00 |
| 52 Week High | $74.88 | $159.42 |
| Indicator | GSAT | DVA |
|---|---|---|
| Relative Strength Index (RSI) | 47.60 | 54.34 |
| Support Level | $55.65 | $146.00 |
| Resistance Level | $65.94 | $150.69 |
| Average True Range (ATR) | 3.56 | 4.69 |
| MACD | 0.08 | -1.71 |
| Stochastic Oscillator | 43.87 | 22.81 |
Globalstar Inc is a telecommunications company that derives revenue from the provision of mobile satellite services. Mobile satellite services, including voice and data communications services to retail, business, and governmental customers, as well as wholesale satellite capacity services. The company provides communications services such as two-way voice and data transmission. In addition, one-way data transmission is also offered. Both services are offered using mobile or fixed devices. The company is the owner of satellite assets. It has one reportable segment: the MSS business. The company generates the vast majority of its revenue within the United States.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.